Trial · NCT02260193
Results by group231
Each measurement the trial posted, group by group, in the words and numbers it posted.
1 to 20 of 231
Download this page as JSON| Outcome | Group | Category | Value | Spread | Units |
|---|---|---|---|---|---|
| Change From Pre-dose Average in Hemoglobin (Hgb) Level to The Mid-study Average | Vadadustat 300 mg Once Daily (QD) | Pre-dose Average | 10.43 | Standard Deviation 0.645 | Grams per deciliter (g/dL) |
| Change From Pre-dose Average in Hemoglobin (Hgb) Level to The Mid-study Average | Vadadustat 450 mg QD | Pre-dose Average | 10.55 | Standard Deviation 0.577 | Grams per deciliter (g/dL) |
| Change From Pre-dose Average in Hemoglobin (Hgb) Level to The Mid-study Average | Vadadustat 450 mg 3 Times Per Week (TIW) | Pre-dose Average | 10.52 | Standard Deviation 0.534 | Grams per deciliter (g/dL) |
| Change From Pre-dose Average in Hemoglobin (Hgb) Level to The Mid-study Average | Vadadustat 300 mg Once Daily (QD) | Change from pre-dose average to the mid-study average | 0.00 | Standard Deviation 0.897 | Grams per deciliter (g/dL) |
| Change From Pre-dose Average in Hemoglobin (Hgb) Level to The Mid-study Average | Vadadustat 450 mg QD | Change from pre-dose average to the mid-study average | -0.29 | Standard Deviation 0.970 | Grams per deciliter (g/dL) |
| Change From Pre-dose Average in Hemoglobin (Hgb) Level to The Mid-study Average | Vadadustat 450 mg 3 Times Per Week (TIW) | Change from pre-dose average to the mid-study average | -0.36 | Standard Deviation 1.134 | Grams per deciliter (g/dL) |
| Change From Pre-dose Average in Hgb Level to The End-of-study Average | Vadadustat 300 mg Once Daily (QD) | Pre-dose Average | 10.43 | Standard Deviation 0.645 | g/dL |
| Change From Pre-dose Average in Hgb Level to The End-of-study Average | Vadadustat 450 mg QD | Pre-dose Average | 10.55 | Standard Deviation 0.577 | g/dL |
| Change From Pre-dose Average in Hgb Level to The End-of-study Average | Vadadustat 450 mg 3 Times Per Week (TIW) | Pre-dose Average | 10.52 | Standard Deviation 0.534 | g/dL |
| Change From Pre-dose Average in Hgb Level to The End-of-study Average | Vadadustat 300 mg Once Daily (QD) | Change From Pre-dose average to The End-of-study Average | -0.03 | Standard Deviation 0.902 | g/dL |
| Change From Pre-dose Average in Hgb Level to The End-of-study Average | Vadadustat 450 mg QD | Change From Pre-dose average to The End-of-study Average | -0.07 | Standard Deviation 0.973 | g/dL |
| Change From Pre-dose Average in Hgb Level to The End-of-study Average | Vadadustat 450 mg 3 Times Per Week (TIW) | Change From Pre-dose average to The End-of-study Average | -0.14 | Standard Deviation 1.123 | g/dL |
| Change From Mid-study Average in Hgb Level to The End-of-study Average | Vadadustat 300 mg Once Daily (QD) | Mid-study Average | 10.41 | Standard Deviation 0.834 | g/dL |
| Change From Mid-study Average in Hgb Level to The End-of-study Average | Vadadustat 450 mg QD | Mid-study Average | 10.26 | Standard Deviation 1.167 | g/dL |
| Change From Mid-study Average in Hgb Level to The End-of-study Average | Vadadustat 450 mg 3 Times Per Week (TIW) | Mid-study Average | 10.19 | Standard Deviation 0.950 | g/dL |
| Change From Mid-study Average in Hgb Level to The End-of-study Average | Vadadustat 300 mg Once Daily (QD) | Change From Mid-study Average to The End-of-study Average | -0.18 | Standard Deviation 0.512 | g/dL |
| Change From Mid-study Average in Hgb Level to The End-of-study Average | Vadadustat 450 mg QD | Change From Mid-study Average to The End-of-study Average | 0.16 | Standard Deviation 0.809 | g/dL |
| Change From Mid-study Average in Hgb Level to The End-of-study Average | Vadadustat 450 mg 3 Times Per Week (TIW) | Change From Mid-study Average to The End-of-study Average | -0.07 | Standard Deviation 0.611 | g/dL |
| Change From Baseline in Hgb | Vadadustat 300 mg Once Daily (QD) | Baseline | 10.50 | Standard Deviation 0.702 | g/dL |
| Change From Baseline in Hgb | Vadadustat 450 mg QD | Baseline | 10.51 | Standard Deviation 0.755 | g/dL |
Source ClinicalTrials.govtrials-2026-11-12-0.5.0
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/trials/v1/NCT02260193/results